OABI - OmniAb, Inc. -  [ ]

Ticker Details
OmniAb, Inc.
IPO Date: September 30, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $324.74M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.11 | 3.39%
Avg Daily Range (30 D): $0.13 | 5.29%
Avg Daily Range (90 D): $0.09 | 4.42%
Institutional Daily Volume
Avg Daily Volume: .42M
Avg Daily Volume (30 D): .46M
Avg Daily Volume (90 D): .47M
Trade Size
Avg Trade Size (Sh.): 120
Avg Trade Size (Sh.) (30 D): 97
Avg Trade Size (Sh.) (90 D): 123
Institutional Trades
Total Institutional Trades: 121
Avg Institutional Trade: $1.54M
Avg Institutional Trade (30 D): $1.3M
Avg Institutional Trade (90 D): $1.41M
Avg Institutional Trade Volume: .54M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.59M
Avg Closing Trade (30 D): $1.3M
Avg Closing Trade (90 D): $1.2M
Avg Closing Volume: 476.1K
 
News
Jul 6, 2026 @ 11:00 AM
VERAXA Biotech Provides Business Update and Furthe...
Source: Veraxa Biotech Ag
Jun 30, 2025 @ 1:50 PM
AI Is Quietly Reinventing Healthcare--And Real Dep...
Source: Prnewswire
May 5, 2025 @ 4:59 PM
VERAXA Biotech Enters Co-discovery Alliance with O...
Source: N/A
Apr 30, 2024 @ 9:55 PM
USANA Health Sciences (USNA) Q1 Earnings and Reven...
Source: Zacks Equity Research
Mar 26, 2024 @ 12:40 PM
Over $1M Bet On OmniAb? Check Out These 3 Stocks I...
Source: Avi Kapoor
Financials
  TTM Q4 2025 FY 2025
Basic EPS $-.06 $-.11 $-.57
Diluted EPS $-.06 $-.11 $-.57
Revenue $14.43M $8.38M $18.67M
Gross Profit
Net Income / Loss $-7.71M $-14.18M $-64.78M
Operating Income / Loss $-7.83M $-15.77M $-68.97M
Cost of Revenue
Net Cash Flow $M $-3.01M $-2.07M
PE Ratio